Raffaella Rusconi
Overview
Explore the profile of Raffaella Rusconi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
1073
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klinkenberg M, Helwig M, Pinto-Costa R, Rollar A, Rusconi R, Di Monte D, et al.
Cells
. 2023 Feb;
12(4).
PMID: 36831238
Neuron-to-neuron transfer of pathogenic α-synuclein species is a mechanism of likely relevance to Parkinson's disease development. Experimentally, interneuronal α-synuclein spreading from the low brainstem toward higher brain regions can be...
2.
May P, Girard S, Harrer M, Bobbili D, Schubert J, Wolking S, et al.
Lancet Neurol
. 2018 Jul;
17(8):699-708.
PMID: 30033060
Background: Genetic generalised epilepsy is the most common type of inherited epilepsy. Despite a high concordance rate of 80% in monozygotic twins, the genetic background is still poorly understood. We...
3.
Rusconi R, Ulusoy A, Aboutalebi H, Di Monte D
Aging Cell
. 2018 Feb;
17(2).
PMID: 29383832
Increased expression of α-synuclein can initiate its long-distance brain transfer, representing a potential mechanism for pathology spreading in age-related synucleinopathies, such as Parkinson's disease. In this study, the effects of...
4.
The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice
Migdalska-Richards A, Wegrzynowicz M, Rusconi R, Deangeli G, Di Monte D, Spillantini M, et al.
Brain
. 2017 Oct;
140(10):2706-2721.
PMID: 28969384
Mutations in glucocerebrosidase 1 (GBA1) represent the most prevalent risk factor for Parkinson's disease. The molecular mechanisms underlying the link between GBA1 mutations and Parkinson's disease are incompletely understood. We...
5.
Foglieni C, Rusconi R, Mantione M, Fragasso G, Alfieri O, Maisano F
Int J Cardiol
. 2016 Jul;
219:433-8.
PMID: 27372606
Objective: Left atrial (LA) enlargement, a compensatory mechanism in chronic mitral regurgitation (MR) increasing the risk of atrial fibrillation (AF) and predictive of cardiac events, involves structural alterations. We characterized...
6.
Helwig M, Klinkenberg M, Rusconi R, Musgrove R, Majbour N, El-Agnaf O, et al.
Brain
. 2016 Jan;
139(Pt 3):856-70.
PMID: 26719384
Aggregation and neuron-to-neuron transmission are attributes of α-synuclein relevant to its pathogenetic role in human synucleinopathies such as Parkinson's disease. Intraparenchymal injections of fibrillar α-synuclein trigger widespread propagation of amyloidogenic...
7.
Ulusoy A, Musgrove R, Rusconi R, Klinkenberg M, Helwig M, Schneider A, et al.
Acta Neuropathol Commun
. 2015 Apr;
3:13.
PMID: 25853980
Introduction: Interneuronal propagation of α-synuclein has been demonstrated in a variety of experimental models and may be involved in disease progression during the course of human synucleinopathies. The aim of...
8.
Bechi G, Rusconi R, Cestele S, Striano P, Franceschetti S, Mantegazza M
Neurobiol Dis
. 2015 Jan;
75:100-14.
PMID: 25576396
Mutations of the voltage gated Na(+) channel Na(V)1.1 (SCN1A) are important causes of different genetic epilepsies and can also cause familial hemiplegic migraine (FHM-III). In previous studies, some rescuable epileptogenic...
9.
Cestele S, Schiavon E, Rusconi R, Franceschetti S, Mantegazza M
Proc Natl Acad Sci U S A
. 2013 Oct;
110(43):17546-51.
PMID: 24101488
Familial hemiplegic migraine (FHM) is a rare subtype of migraine with aura. Mutations causing FHM type 3 have been identified in SCN1A, the gene encoding the Nav1.1 Na(+) channel, which...
10.
Liu Y, Lopez-Santiago L, Yuan Y, Jones J, Zhang H, OMalley H, et al.
Ann Neurol
. 2013 Jul;
74(1):128-39.
PMID: 23821540
Objective: Neuronal channelopathies cause brain disorders, including epilepsy, migraine, and ataxia. Despite the development of mouse models, pathophysiological mechanisms for these disorders remain uncertain. One particularly devastating channelopathy is Dravet...